TrialDiabetes care2016

Addition of Liraglutide to Insulin in Patients With Type 1 Diabetes: A Randomized Placebo-Controlled Clinical Trial of 12 Weeks.

Nitesh D Kuhadiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.